HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Tim Illidge Selected Research
Tim Illidge Research Topics
Disease
16
Neoplasms (Cancer)
01/2020 - 01/2004
15
Lymphoma (Lymphomas)
11/2021 - 08/2006
14
Hodgkin Disease (Hodgkin's Disease)
11/2021 - 04/2013
5
Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2021 - 02/2008
5
Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2021 - 02/2008
5
Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
10/2018 - 06/2012
3
Hematologic Neoplasms (Hematological Malignancy)
01/2020 - 02/2007
3
B-Cell Lymphoma (Lymphoma, B Cell)
01/2020 - 02/2007
3
Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
01/2019 - 10/2014
2
Peripheral Nervous System Diseases (PNS Diseases)
01/2018 - 12/2017
2
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
07/2011 - 07/2007
1
Oropharyngeal Neoplasms
10/2022
1
Hypoxia (Hypoxemia)
11/2021
1
Urinary Bladder Neoplasms (Bladder Cancer)
11/2021
1
Cardiovascular Diseases (Cardiovascular Disease)
11/2021
1
Infections
01/2020
1
COVID-19
01/2020
1
Anemia
01/2018
1
Diarrhea
01/2018
1
Leukopenia
01/2018
1
Kidney Neoplasms (Kidney Cancer)
11/2016
1
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
11/2015
1
Disease Progression
04/2015
1
Hemorrhage
07/2007
1
Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
08/2006
1
Brain Neoplasms (Brain Tumor)
01/2004
Drug/Important Bio-Agent (IBA)
9
Brentuximab Vedotin
IBA
01/2019 - 06/2012
7
Monoclonal Antibodies
IBA
01/2020 - 08/2005
6
Rituximab (Mabthera)
FDA Link
01/2020 - 02/2008
5
Doxorubicin (Adriamycin)
FDA Link
Generic
01/2019 - 10/2014
4
Prednisone (Sone)
FDA Link
Generic
01/2019 - 10/2014
4
Cyclophosphamide (Cytoxan)
FDA Link
Generic
01/2019 - 10/2014
3
Vincristine (Oncovin)
FDA Link
Generic
01/2019 - 10/2014
2
Vinblastine (Vinblastine Sulfate)
FDA Link
01/2019 - 04/2015
2
Bleomycin (Blenoxane)
FDA Link
Generic
01/2019 - 04/2015
2
Dacarbazine (DIC)
FDA Link
Generic
01/2019 - 04/2015
2
Pharmaceutical Preparations
IBA
01/2019 - 01/2019
2
Immunoconjugates (Immunoconjugate)
IBA
12/2017 - 03/2015
2
obinutuzumab
IBA
11/2015 - 10/2014
2
Yttrium-90
IBA
07/2007 - 08/2006
2
ibritumomab tiuxetan (Zevalin)
FDA Link
07/2007 - 08/2006
1
B7-H1 Antigen
IBA
11/2021
1
Oxygen (Dioxygen)
IBA
11/2021
1
Etoposide (VP 16)
FDA Link
Generic
01/2019
1
Procarbazine (Matulane)
FDA Link
01/2019
1
Antigens
IBA
02/2007
1
Antibodies
IBA
02/2007
1
CD20 Antigens
IBA
08/2006
1
Complement System Proteins (Complement)
IBA
08/2005
1
motexafin gadolinium
IBA
01/2004
Therapy/Procedure
19
Radiotherapy
10/2022 - 01/2004
12
Therapeutics
11/2021 - 08/2006
8
Drug Therapy (Chemotherapy)
10/2022 - 08/2008
6
Radioimmunotherapy
01/2020 - 08/2006
2
Stem Cell Transplantation
01/2018 - 07/2007
2
Immunotherapy
11/2016 - 02/2008
1
Image-Guided Radiotherapy
07/2014
1
Homologous Transplantation
04/2013
1
Combined Modality Therapy
07/2011
1
Induction Chemotherapy
02/2008